5NF-32632-06367
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 386 / MS
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Health check-in — day 0, dose 1Feeling: Good · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-17
Survey response — day 14, dose 1MedDRA: Fatigue, Pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Increased fatigue and pain responseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-23
Call successfulParticipant prefers to complete VAERS report online
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-03 | Successful | Participant prefers to complete VAERS report online |
| 2021-03-17 | Successful 2021-03-23 |
Participant prefers to complete VAERS report online |
Free text
Release 5 — day 14, dose 1
Symptoms: Increased fatigue and pain response
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release